Corporate StrategyThe proposed separation of MASI's consumer business is consistent with the company’s prior commitment to reassess the consumer business strategy.
Financial ForecastInvestors anticipate a clean, standalone Healthcare business with improving EBIT margin and the ability to generate strong, consistent free cash flow.
Stock UpgradeAnalyst recommends upgrading MASI to Buy from Hold, with a target price increase to $170 from $148.